- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06736886
Effect of Light Color Temperature Applied During Breastfeeding on Mother's Stress, Anxiety, Peace and Breastfeeding Motivation
December 15, 2024 updated by: Emine Yıldırım, Osmaniye Korkut Ata University
Effect of Light Color Temperature Applied During Breastfeeding on Mother's Stress, Anxiety, Peace and Breastfeeding Motivation: A Randomized Controlled Trial
Breastfeeding is an important condition for the health of the mother and the baby, which is the most difficult for mothers after birth.
Since it is an important practice for both the mother and the baby, the evaluation and reduction of the mother's stress factors can help the hospital to regulate the lighting of the breastfeeding room.
In addition, setting the light color temperature to a more appropriate kelvin can make a positive contribution to the hospital in terms of costs.
For this purpose, when researchers look at the literature, we have not come across a randomized controlled study examining the effect of the light color temperature applied during breastfeeding on the mother's stress, anxiety, peace and breastfeeding motivation.
Researchers' purpose is to determine the effect of the light color temperature applied during breastfeeding on the mother's stress, anxiety, peace and breastfeeding motivation.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emine Yıldırım, Assistant Professor
- Phone Number: 05066268672
- Email: eminekucukyildirim@gmail.com
Study Contact Backup
- Name: Emine Yıldırım
- Phone Number: 05066268672
- Email: emineyildirim@osmaniye.edu.tr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Mothers who have given birth for the first time,
- being 18 years of age and older,
- volunteering.
Exclusion Criteria:
- Being a mother who has given birth to more than one child,
- having any problem that prevents communication (such as not knowing Turkish, having hearing, speaking and understanding disorders),
- receiving psychiatric treatment (pharmacotherapy or psychotherapy),
- having a disease that prevents vision.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Light application
|
Light application
|
|
Placebo Comparator: control group
Light application
|
Light application
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
stress scale
Time Frame: 2 minutes
|
QUESTIONNAIRE
|
2 minutes
|
|
anxiety scale
Time Frame: 2 minutes
|
QUESTIONNAIRE
|
2 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 25, 2024
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
January 15, 2025
Study Registration Dates
First Submitted
December 5, 2024
First Submitted That Met QC Criteria
December 15, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 15, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2053231
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Can be shared when necessary
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.